Synthesis and biological evaluation of novel chiral diazepine derivatives as bombesin receptor subtype-3 (BRS-3) agonists incorporating an antedrug approach

被引:17
|
作者
Matsufuji, Tetsuyoshi [1 ]
Shimada, Kousei [1 ]
Kobayashi, Shozo [1 ]
Ichikawa, Masanori [1 ]
Kawamura, Asuka [1 ]
Fujimoto, Teppei [1 ]
Arita, Tsuyoshi [1 ]
Hara, Takashi [2 ]
Konishi, Masahiro [2 ]
Abe-Ohya, Rie [2 ]
Izumi, Masanori [2 ]
Sogawa, Yoshitaka [2 ]
Nagai, Yoko [3 ]
Yoshida, Kazuhiro [3 ]
Abe, Yasuyuki [4 ]
Kimura, Takako [5 ]
Takahashi, Hisashi [1 ]
机构
[1] Daiichi Sankyo Co Ltd, Med Chem Res Labs, Shinagawa Ku, Tokyo 1408710, Japan
[2] Daiichi Sankyo Co Ltd, Cardiovasc Metabol Res Labs, Shinagawa Ku, Tokyo 1408710, Japan
[3] Daiichi Sankyo Co Ltd, Drug Metab & Pharmacokinet Res Labs, Shinagawa Ku, Tokyo 1408710, Japan
[4] Daiichi Sankyo Co Ltd, Med Safety Res Labs, Edogawa Ku, Tokyo 1348630, Japan
[5] Daiichi Sankyo RD NOVARE Co Ltd, Drug Discovery & Biomed Technol Unit, Edogawa Ku, Tokyo 1348630, Japan
关键词
Anti-obesity; Antedrug; Bombesin receptor subtype-3 (BRS-3); Brain penetration; Diazepine; TERT-BUTANESULFINYL IMINES; ASYMMETRIC-SYNTHESIS; BODY-TEMPERATURE; NERVOUS-SYSTEM; OBESE SUBJECTS; WEIGHT-LOSS; DISCOVERY; OVERWEIGHT; AMINES; SIBUTRAMINE;
D O I
10.1016/j.bmc.2014.11.018
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Novel compounds based on the lead BRS-3 agonists from our HTS compounds 2a and 2b have been synthesized with the focus on obtaining peripheral BRS-3 agonists. To identify potent anti-obesity compounds without adverse effects on the central nerve system, a labile carboxylic ester with an antedrug functionality was introduced onto the terminal position. Through the extensive synthetic exploration and the pharmacokinetic studies of oral administration in mice, the phenol ester 17c was selected due to the most suitable pharmacological profile. In the evaluation of food intake suppression in B6 mice, 17c showed significant in vivo efficacy and no clear adverse effect on heart rate and blood pressure change in dog iv infusion. Our study paved the way for development of anti-diabetes and obesity drugs with a safer profile. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:89 / 104
页数:16
相关论文
共 50 条
  • [31] A Combined DFT and QSAR Calculations to Study Substituted Biphenyl imidazoles as Bombesin Receptor Subtype-3 Agonists
    Shahlaei, Mohsen
    Nowroozi, Amin
    Khodarahmi, Reza
    LETTERS IN DRUG DESIGN & DISCOVERY, 2014, 11 (05) : 665 - 676
  • [32] Bombesin receptor subtype-3 agonists stimulate the growth of lung cancer cells and increase EGF receptor tyrosine phosphorylation
    Moody, Terry W.
    Sancho, Veronica
    di Florio, Alessia
    Nuche-Berenguer, Bernardo
    Mantey, Samuel
    Jensen, Robert T.
    PEPTIDES, 2011, 32 (08) : 1677 - 1684
  • [33] Body temperature as a mouse pharmacodynamic response to bombesin receptor subtype-3 agonists and other potential obesity treatments
    Metzger, Joseph M.
    Gagen, Karen
    Raustad, Kate A.
    Yang, Liming
    White, Amanda
    Wang, Sheng-Ping
    Craw, Stephanie
    Liu, Ping
    Lanza, Thomas
    Lin, Linus S.
    Nargund, Ravi P.
    Guan, Xiao-Ming
    Strack, Alison M.
    Reitman, Marc L.
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2010, 299 (05): : E816 - E824
  • [34] The orphan receptor, BRS-3, has a unique pharmacology for naturally occurring agonists and synthetic antagonists of the bombesin (BN) family of receptors.
    Mantey, SA
    Weber, HC
    Sainz, E
    Ryan, RR
    Pradhan, TK
    Spindel, ER
    Battey, JF
    Coy, DC
    Jensen, RT
    GASTROENTEROLOGY, 1997, 112 (04) : A1168 - A1168
  • [35] Novel chiral-diazepines function as specific, selective receptor agonists with variable coupling and species variability in human, mouse and rat BRS-3 receptor cells
    Ramos-Alvarez, Irene
    Nakamura, Taichi
    Mantey, Samuel A.
    Moreno, Paola
    Nuche-Berenguer, Bernardo
    Jensen, Robert T.
    PEPTIDES, 2016, 75 : 8 - 17
  • [36] THE BOMBESIN RECEPTOR SUBTYPE3 (BRS-3) AGONIST, MK-5046, FUNCTIONS AS AN ALLOSTERIC AGONIST IN RAT, MOUSE, HUMAN BUT VARIES IN BASIS FOR ALLOSTERISM
    Mantey, Samuel A.
    Ramos, Irene
    Iordanskaia, Tatiana
    Lee, Lingaku
    Jensen, Robert T.
    GASTROENTEROLOGY, 2018, 154 (06) : S503 - S503
  • [37] Immunohistochemical detection of bombesin receptor subtypes GRP-R and BRS-3 in human tumors using novel antipeptide antibodies
    Solveig Schulz
    Christoph Röcken
    Stefan Schulz
    Virchows Archiv, 2006, 449 : 421 - 427
  • [38] DIFFERENT CLASSES OF NONPEPTIDE AGONISTS HAVE A DIFFERENT MOLECULAR BASIS FOR THEIR AFFINITY/SELECTIVITY FOR THE HUMAN BOMBESIN RECEPTOR SUBTYPE-3, HBRS-3
    Ramos, Irene
    Iordanskaia, Tatiana
    Mantey, Samuel A.
    Jensen, Robert T.
    GASTROENTEROLOGY, 2020, 158 (06) : S1014 - S1014
  • [39] Immunohistochemical detection of bombesin receptor subtypes GRP-R and BRS-3 in human tumors using novel antipeptide antibodies
    Schulz, Solveig
    Roecken, Christoph
    Schulz, Stefan
    VIRCHOWS ARCHIV, 2006, 449 (04) : 421 - 427
  • [40] Synthesis and Biological Evaluation of 8-Oxoadenine Derivatives as Toll-like Receptor 7 Agonists Introducing the Antedrug Concept
    Kurimoto, Ayumu
    Hashimoto, Kazuki
    Nakamura, Tomoaki
    Norimura, Kei
    Ogita, Haruhisa
    Takaku, Haruo
    Bonnert, Roger
    McInally, Tom
    Wada, Hiroki
    Isobe, Yoshiaki
    JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (07) : 2964 - 2972